Show simple item record

dc.contributor.authorAgrawal, Nitasha
dc.contributor.authorEsteve-Romero, Josep
dc.contributor.authorBose, Devasish
dc.contributor.authorDubey, Neeti Prakash
dc.contributor.authorPeris Vicente, Juan
dc.contributor.authorCarda-Broch, Samuel
dc.date.accessioned2015-06-23T09:25:04Z
dc.date.available2015-06-23T09:25:04Z
dc.date.issued2015-06-23
dc.identifier.issn1570-0232
dc.identifier.urihttp://hdl.handle.net/10234/124843
dc.description.abstractCitalopram, paroxetine and fluoxetine are selective serotonin reuptake inhibitor (SSRIs) currently used in the treatment of psychiatric disorders. We present an analytical method using micellar liquid chromatography to quantify these three drugs in pharmaceutical formulations, plasma and urine. The resolution was performed using a mobile phase of 0.075 M SDS – 6% (v/v) butanol buffered at pH 7 running through a C18 column under isocratic mode at 1 mL/min at 25 °C. The analytes were eluted in less than 20 min. The fluorescence detection was programmed at the maximum excitation (236, 295 and 230 nm) and emission (310, 350 and 305 nm) wavelengths for citalopram, paroxetine and fluoxetine, respectively. The experimental procedure was expedited to 1/5 dilution of the sample in the micellar mobile phase and filtration, thus avoiding clean-up and extraction steps. An aliquot of 20 μL was injected after 80 min of preparation, to obtain maximum sensitivity. The method was validated according to the guidelines of the Food and Drug Administration (FDA) in terms of calibration range (20–500 ng/mL; r2 > 0.999), sensitivity, accuracy (91.3–103.2%), precision (<9.3%), and robustness (<6.1%). The suitability of the method was successfully evaluated by analyzing plasma and urine samples from patients treated with SSRIs and checking the content of the active principle in tablets. Thus, the method can be applied to pharmacokinetics studies and in forensic cases, as well as in quality control of commercial pharmaceutical formulations.ca_CA
dc.format.extent8 p.ca_CA
dc.language.isoengca_CA
dc.relation.isPartOfJournal of Chromatography B, 2014, 965: 142-149ca_CA
dc.rightsCopyright © 2014 Elsevier B.V. All rights reserved.ca_CA
dc.subjectAntidepressantca_CA
dc.subjectMicellar liquid chromatographyca_CA
dc.subjectFluorescenceca_CA
dc.subjectPlasmaca_CA
dc.subjectUrineca_CA
dc.subjectValidationca_CA
dc.titleDetermination of selective serotonin reuptake inhibitors in plasma and urine by micellar liquid chromatography coupled to fluorescence detectionca_CA
dc.typeinfo:eu-repo/semantics/articleca_CA
dc.identifier.doi10.1016/j.jchromb.2014.06.026
dc.rights.accessRightsinfo:eu-repo/semantics/restrictedAccessca_CA
dc.relation.publisherVersionhttp://www.sciencedirect.com/science/article/pii/S1570023214004449ca_CA


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record